Wu R - Search Results

1

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol.

Zhu H, Ding WJ, Wu R, Weng QJ, Lou JS, Jin RJ, Lu W, Yang B, He QJ. Zhu H, et al. Among authors: wu r. Cancer Invest. 2010 Jan;28(1):23-32. doi: 10.3109/07357900903095664. Cancer Invest. 2010. PMID: 19916747

2

Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.

Xue N, Yang X, Wu R, Chen J, He Q, Yang B, Lu X, Hu Y. Xue N, et al. Among authors: wu r. Bioorg Med Chem. 2008 Mar 1;16(5):2550-7. doi: 10.1016/j.bmc.2007.11.048. Epub 2007 Nov 22. Bioorg Med Chem. 2008. PMID: 18226907

3

ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.

Cao J, Xu D, Wang D, Wu R, Zhang L, Zhu H, He Q, Yang B. Cao J, et al. Among authors: wu r. Free Radic Biol Med. 2009 Sep 1;47(5):536-47. doi: 10.1016/j.freeradbiomed.2009.05.024. Epub 2009 May 28. Free Radic Biol Med. 2009. PMID: 19482076

4

XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.

Wu R, Ding W, Liu T, Zhu H, Hu Y, Yang B, He Q. Wu R, et al. Cancer Lett. 2009 Nov 18;285(1):13-22. doi: 10.1016/j.canlet.2009.04.042. Epub 2009 Aug 3. Cancer Lett. 2009. PMID: 19647933

5

Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.

Liu T, Dong X, Xue N, Wu R, He Q, Yang B, Hu Y. Liu T, et al. Among authors: wu r. Bioorg Med Chem. 2009 Sep 1;17(17):6279-85. doi: 10.1016/j.bmc.2009.07.040. Epub 2009 Jul 23. Bioorg Med Chem. 2009. PMID: 19665898

6

Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo.

Ding W, Cai T, Zhu H, Wu R, Tu C, Yang L, Lu W, He Q, Yang B. Ding W, et al. Among authors: wu r. Cancer Lett. 2010 Jul 28;293(2):158-66. doi: 10.1016/j.canlet.2010.01.005. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137855

7

Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents.

Chen J, Liu T, Wu R, Lou J, Cao J, Dong X, Yang B, He Q, Hu Y. Chen J, et al. Among authors: wu r. Bioorg Med Chem. 2010 Dec 15;18(24):8478-84. doi: 10.1016/j.bmc.2010.10.047. Epub 2010 Oct 25. Bioorg Med Chem. 2010. PMID: 21067933

8

Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.

Zhang J, Cao J, Weng Q, Wu R, Yan Y, Jing H, Zhu H, He Q, Yang B. Zhang J, et al. Among authors: wu r. PLoS One. 2010 Nov 9;5(11):e13910. doi: 10.1371/journal.pone.0013910. PLoS One. 2010. PMID: 21085474 Free PMC article.

9

Enhanced anti-tumor activity by the combination of TRAIL/Apo-2L and combretastatin A-4 against human colon cancer cells via induction of apoptosis in vitro and in vivo.

Zhang C, Wu R, Zhu H, Hu YZ, Jiang H, Lin NM, He QJ, Yang B. Zhang C, et al. Among authors: wu r. Cancer Lett. 2011 Mar 1;302(1):11-9. doi: 10.1016/j.canlet.2010.12.001. Epub 2011 Jan 14. Cancer Lett. 2011. PMID: 21236562

10

Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents.

Chen J, Liu T, Wu R, Lou J, Dong X, He Q, Yang B, Hu Y. Chen J, et al. Among authors: wu r. Eur J Med Chem. 2011 Apr;46(4):1343-7. doi: 10.1016/j.ejmech.2011.01.057. Epub 2011 Feb 20. Eur J Med Chem. 2011. PMID: 21342735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,919 results

Search Page

Filters